David Einhorn acquired 392 Thousand Coya Therapeutics shares worth $1.59 Million. That's 0.10% of their equity portfolio (29th largest holding). The investor owns 4.05% of the outstanding Coya Therapeutics stock. The investor's estimated purchase price is $1.83 Million, resulting in a loss of 13%.